---

#JBCHEPHARM The acquisition will mark JBCPL’s entry into the fast-growing probiotics, therapeutic nutraceuticals and reproductive health market with attractive set

of brands

• Will be amongst the top five probiotics players in the country, in a segment which is growing at around 12 -14%. This category creates synergies with its strong prescriber base in gastroenterology and nephrology segments.

• Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise